PARIS (Reuters) - The French government needs guarantees from drugmaker Sanofi that production of its popular Doliprane ...

US private equity firm CD&R has agreed to French government demands seeking to protect jobs and investment in France. View on ...

Sanofi confirmed on Monday plans to sell a controlling stake in its over-the-counter unit to a US investment fund, ...

French pharmaceutical company Sanofi confirmed on Monday its plans to sell a controlling stake in its consumer health ...

Deal for consumer health arm has faced a political backlash over ceding controlling stake to American private equity group ...

Under the proposed deal, the PE firm would take a controlling 50% stake in Sanofi’s Opella unit, with state-owned Bpifrance ...

Building on the expertise and radioligand pipeline of Orano Med, Sanofi and Orano will invest in a new entity, operating ...

French pharamceutical giant Sanofi has confirmed plans to sell a controlling stake in its over-the-counter unit to a US ...

The US buyout firm is pairing with the French pharma giant to buy out its consumer unit. Success here requires much more than ...

Sanofi is now in “exclusive negotiations” with U.S. private equity firm Clayton, Dubilier & Rice (CD&R) to sell a 50% ...

Clayton Dubilier & Rice is set to buy Sanofi's consumer health unit with social commitments, including job creation ...

PARIS, France — Sanofi confirmed on Monday plans to sell a controlling stake in its over-the-counter unit to a US investment fund, after employment and investment guarantees relieved political ...